Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy for Resectable Pancreatic Cancer. A Multifactorial Analysis of Metabolic Dysfunction

NCT07182136 is registered in ClinicalTrials.gov with Wei-Hsun Lu as lead sponsor.

NCT NCT07182136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy for Resectable Pancreatic Cancer. A Multifactorial Analysis of Metabolic Dysfunction
Lead sponsor
Wei-Hsun Lu
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
January 1, 2025
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver disease after pancreaticoduodenectomy